Ireland
--:--IST
Latest
Clinical Trials in Portugal / NCT07415915
Enrolling by invitation Not applicable

HRVB for Stress and Anxiety During Dentistry Students' Clinical Transition

NCT07415915 · tracked via the Priya Life Science Portugal tracker
Phase
Not applicable
Started
2026-02
Last updated
2026-02-20

Condition(s) studied

Stress (Psychology)AnxietyPsychological Distress

Investigational drug(s) / intervention(s)

Heart Rate Variability Biofeedback (HRVB) Training

Heart Rate Variability Biofeedback (HRVB) Training: Participants complete a 5-week HRVB protocol consisting of 10 sessions delivered twice weekly (about 10 minutes per session). During each session, participants practice slow-paced breathing (approximately 6 breaths per minute) while recalling a positive memory and receive real-time biofeedback in a game format using an HRV biofeedback device. In addition, participants are asked to practice the breathing exercise daily

Study summary

The goal of this clinical trial is to learn if Heart Rate Variability Biofeedback (HRVB) can reduce stress and anxiety in dentistry students during the transition from pre-clinical training to clinical practice.

The main questions this study aims to answer are:

1. Does HRVB training reduce perceived stress, measured with the Perceived Stress Scale (PSS-10), from baseline to post-intervention and to 2-month follow-up?
2. Does HRVB training reduce psychological distress, measured with the Kessler Psychological Distress Scale, 10-item version (K-10), from baseline to post-intervention and to 2-month follow-up?
3. Does HRVB training reduce anxiety, measured with the State-Trait Anxiety Inventory, Form Y, State subscale state anxiety (STAI Y-1), from baseline to post-intervention and to 2-month follow-up?

Researchers will compare an HRVB training group to a control group (no intervention) to see if HRVB leads to greater improvements in stress, distress, and anxiety across the study time points.

Participants will:

* Receive study information and provide electronic informed consent.
* Complete online baseline questionnaires (sociodemographic questionnaire, K-10, PSS-10, and STAI Y-1).
* Be randomly assigned to one of two groups: HRVB training or control (no intervention).
* If assigned to the HRVB group, complete a 5-week program with 10 sessions (twice per week; about 10 minutes per session) using an emWave2 HRVB device; participants will practice slow breathing (about 6 breaths per minute) while recalling a positive memory, with real-time feedback provided in a game format.
* If assigned to the HRVB group, practice the breathing exercise daily.
* If assigned to the control group, not receive HRVB sessions or daily breathing training as part of the study, and only complete the study assessments at the scheduled time points.
* Complete the post-intervention assessment online after the intervention period (same questionnaires as baseline except the sociodemographic questionnaire).
* Complete a follow-up assessment online about 2 months after the end of the intervention period; participants will be contacted by email to complete this follow-up questionnaire.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Enrolled in the Integrated Master's in Dentistry at Egas Moniz School of Health and Science. * Attending the 4th year of the program for the first time (transition from pre-clinical to clinical training). * Able to provide informed consent autonomously. Exclusion Criteria: * Initiation or change in the last 6 months of psychopharmacological medication or psychotherapy (including psychological support/supportive psychotherapy) * Diagnosed psychiatric disorder. * Regular use (more than twice per week) of psychotropic substances.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Egas Moniz School of Health and Science Almada Setúbal District

More Egas Moniz - Cooperativa de Ensino Superior, CRL trials in Portugal

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07415915 on ClinicalTrials.gov ↗ ← All trials in Portugal